» Articles » PMID: 32788173

YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of

Overview
Journal Cancer Res
Specialty Oncology
Date 2020 Aug 14
PMID 32788173
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

N-methyladenosine (mA) is the most prevalent internal RNA modification in mammals that regulates homeostasis and function of modified RNA transcripts. Here, we aimed to investigate the role of YTH mA RNA-binding protein 1 (YTHDF1), a key regulator of mA methylation in gastric cancer tumorigenesis. Multiple bioinformatic analyses of different human cancer databases identified key mA-associated genetic mutations that regulated gastric tumorigenesis. was mutated in about 7% of patients with gastric cancer, and high expression of YTHDF1 was associated with more aggressive tumor progression and poor overall survival. Inhibition of attenuated gastric cancer cell proliferation and tumorigenesis and . Mechanistically, YTHDF1 promoted the translation of a key Wnt receptor frizzled7 () in an mA-dependent manner, and mutated enhanced expression of FZD7, leading to hyperactivation of the Wnt/β-catenin pathway and promotion of gastric carcinogenesis. Our results demonstrate the oncogenic role of and its mA-mediated regulation of Wnt/β-catenin signaling in gastric cancer, providing a novel approach of targeting such epigenetic regulators in this disease. SIGNIFICANCE: This study provides a rationale for controlling translation of key oncogenic drivers in cancer by manipulating epigenetic regulators, representing a novel and efficient strategy for anticancer treatment. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/10/2651/F1.large.jpg.

Citing Articles

Identification of FZD7 as a potential ferroptosis-related diagnostic gene in endometriosis by bioinformatics analysis.

Huang J, Li J, Li X, Guo H, Chen S Sci Rep. 2025; 15(1):7172.

PMID: 40021920 PMC: 11871347. DOI: 10.1038/s41598-025-90803-9.


YTH N-methyladenosine RNA Binding Protein 1 Inhibits Smooth Muscle Cell Phenotypic Modulation and Neointimal Hyperplasia.

Tian K, Cai D, Yang S, Zhao W, Mei X, Chen S Cells. 2025; 14(3).

PMID: 39936952 PMC: 11817666. DOI: 10.3390/cells14030160.


Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.

Pilala K, Panoutsopoulou K, Papadimitriou M, Soureas K, Scorilas A, Avgeris M Mol Ther. 2024; 33(2):447-464.

PMID: 39659016 PMC: 11852398. DOI: 10.1016/j.ymthe.2024.12.003.


RNA N-Methyladenosine-Binding Protein YTHDFs Redundantly Attenuate Cancer Immunity by Downregulating IFN-γ Signaling in Gastric Cancer.

Jang D, Hwa C, Kim S, Oh J, Shin S, Lee S Adv Sci (Weinh). 2024; 12(3):e2410806.

PMID: 39587835 PMC: 11744580. DOI: 10.1002/advs.202410806.


N6-Methyladenosine methylation modification in breast cancer: current insights.

Zhang G, Cheng C, Wang X, Wang S J Transl Med. 2024; 22(1):971.

PMID: 39468547 PMC: 11514918. DOI: 10.1186/s12967-024-05771-x.